» Articles » PMID: 33452456

Small Non-coding RNAs in Human Cancer: Function, Clinical Utility, and Characterization

Overview
Journal Oncogene
Date 2021 Jan 16
PMID 33452456
Citations 35
Authors
Affiliations
Soon will be listed here.
Abstract

Small non-coding RNAs (sncRNAs) play critical roles in multiple regulatory processes, including transcription, post-transcription, and translation. Emerging evidence reveals the critical roles of sncRNAs in cancer development and their potential role as biomarkers and/or therapeutic targets. In this paper, we review recent research on four sncRNA species with functional significance in cancer: small nucleolar RNAs, transfer RNA, small nuclear RNAs, and piwi-interacting RNAs. We introduce their functional roles in tumorigenesis and discuss the potential utility of sncRNAs as prognostic and diagnostic biomarkers and therapeutic targets. We further summarize approaches to characterize sncRNAs in a high-throughput manner, including the specific library construction and computational framework. Our review provides a perspective of the functions, clinical utility, and characterization of sncRNAs in cancer.

Citing Articles

Non-Coding RNAs in Cancer: Structure, Function, and Clinical Application.

Marton E, Varga A, Domoszlai D, Buglyo G, Balazs A, Penyige A Cancers (Basel). 2025; 17(4).

PMID: 40002172 PMC: 11853212. DOI: 10.3390/cancers17040579.


pir-hsa-216911 inhibit pyroptosis in hepatocellular carcinoma by suppressing TLR4 initiated GSDMD activation.

Liao Z, Yang L, Cheng X, Huang X, Zhang Q, Wen D Cell Death Discov. 2025; 11(1):11.

PMID: 39824843 PMC: 11742400. DOI: 10.1038/s41420-024-02285-9.


The Untapped Biomarker Potential of MicroRNAs for Health Risk-Benefit Analysis of Vaping vs. Smoking.

Besaratinia A, Tommasi S Cells. 2024; 13(16.

PMID: 39195220 PMC: 11352591. DOI: 10.3390/cells13161330.


The role of tRF-Val-CAC-010 in lung adenocarcinoma: implications for tumorigenesis and metastasis.

Luo L, Cao Y, Zhang J, Xie Y, Li L, Yang H BMC Cancer. 2024; 24(1):1033.

PMID: 39169309 PMC: 11337561. DOI: 10.1186/s12885-024-12800-x.


A systematic review of non-coding RNA therapeutics in early clinical trials: a new perspective against cancer.

Grillone K, Carida G, Luciano F, Cordua A, Di Martino M, Tagliaferri P J Transl Med. 2024; 22(1):731.

PMID: 39103911 PMC: 11301835. DOI: 10.1186/s12967-024-05554-4.


References
1.
Romano G, Veneziano D, Acunzo M, Croce C . Small non-coding RNA and cancer. Carcinogenesis. 2017; 38(5):485-491. PMC: 6248440. DOI: 10.1093/carcin/bgx026. View

2.
Wong C, Tsang F, Ng I . Non-coding RNAs in hepatocellular carcinoma: molecular functions and pathological implications. Nat Rev Gastroenterol Hepatol. 2018; 15(3):137-151. DOI: 10.1038/nrgastro.2017.169. View

3.
Olson P, Lu J, Zhang H, Shai A, Chun M, Wang Y . MicroRNA dynamics in the stages of tumorigenesis correlate with hallmark capabilities of cancer. Genes Dev. 2009; 23(18):2152-65. PMC: 2751988. DOI: 10.1101/gad.1820109. View

4.
Zheng T, Wang J, Chen X, Liu L . Role of microRNA in anticancer drug resistance. Int J Cancer. 2009; 126(1):2-10. DOI: 10.1002/ijc.24782. View

5.
Grady W, Tewari M . The next thing in prognostic molecular markers: microRNA signatures of cancer. Gut. 2010; 59(6):706-8. PMC: 3377960. DOI: 10.1136/gut.2009.200022. View